YOUNG JAMES EMMETT enters TRISALUS LIFE SCIENCES, INC. with 9.23K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/15/2025ACC: 0001415889-25-001503
Officer· Chief Financial Officer
Since Jan 2025
9.23K
Baseline shares
100% direct
9.23K
Direct ownership
1 position
55K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned9.23K
Total
9.23K direct9.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.23K | Direct |
| Total | 9.23K | 9.23K direct |
Derivative Holdings2
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
12K
Shares owned
N/A
Exercise price
9.50
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
43K
Shares owned
N/A
Exercise price
4.95
Expiration
—
Exercise window
—
Total
Underlying
55K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 9.50 | — | — | 12K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 4.95 | — | — | 43K | N/A |
| Total | 55K | 0.00 | ||||